> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Priority Review Voucher Awarded to Pharming Tech
- URL: https://www.fdaweb.com/priority-review-voucher-awarded-to-pharming-tech/
- Published: 2023-04-21T12:00:00.000Z
- Updated: 2026-09-14T18:26:55.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5154277

*Federal Register* notice: FDA has announced the issuance of a priority review voucher to Pharming Technologies that was related to its rare pediatric disease drug Joenja (leniolisib), which was approved 3/24\. Joenja is indicated for treating activated phosphoinositide 3-kinase delta syndrome, a rare genetic disorder that leads to a weakened immune system. To view the notice, click [here](https://public-inspection.federalregister.gov/2023-08518.pdf?ref=fdaweb.com).